China has administered 9 million doses of its homegrown vaccine to priority groups

A nurse prepares a syringe of the Sputnik V vaccine at a clinic in Moscow on December 28, 2020. Vladimir Gerdo/TASS/Getty Images

Russia’s Gamaleya Institute, which developed the Sputnik V coronavirus vaccine, has applied for emergency use authorization in the Philippines.

The Moscow-based company filed its application on Thursday, according to the Philippines News Agency.

A day before that, Gamaleya withdrew its application to hold clinical trials in the country, according to CNN affiliate CNN Philippines.

Gamaleya is the third vaccine maker — alongside Pfizer-BioNTech and Oxford-AstraZeneca — to apply for emergency use authorization in the Philippines. 

It usually takes the Philippines’ Food and Drug Administration 21 days to decide if a drug or vaccine will be allowed for use in the country, according to CNN Philippines.

Last November, Russia said the Sputnik V vaccine was at least 91.4% effective and could be more than 95% effective, according to data from its Phase 3 trials.



Source link

Leave a comment

%d bloggers like this: